Prosecution Insights
Last updated: October 04, 2026

Ortiv-Q3 Research Pvt Ltd.

Technology area: Chemistry & Materials

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Ortiv-Q3 Research Pvt Ltd. currently manages 1 pending office action within the Chemistry & Materials technology area. This single action represents the entirety of the company's active prosecution before the USPTO. The concentration in Chemistry & Materials suggests that the company's current intellectual property efforts are focused on specific material science or chemical processes.

The portfolio involves 1 distinct examiner and 1 distinct art unit. This structure indicates a highly centralized review process, where all pending matters are handled by a single individual within one technical department. For the practitioner, this means that the prosecution path is not complicated by differing standards across multiple art units or varying examiner interpretations.

Herbert, Madison Taylor is the busiest examiner for the company, with 1 pending office action. Since this examiner is responsible for 1 pending office action, they are the primary point of contact for the company's current applications. Practitioners should tailor their approach to the specific examination style of this individual to effectively advance the company's interests within the Chemistry & Materials sector.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
1
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HERBERT, MADISON TAYLOR 1 59.1% +53.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17919622 SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS HERBERT, MADISON TAYLOR 34d

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17919622 SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS HERBERT, MADISON TAYLOR 34d

Top Art Units

Art UnitApps
1758 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
17919622 SYSTEM AND METHOD FOR MICRODIALYSIS FOR IN-VITRO RELEASE TESTING OF DOSAGE FORMS HERBERT, MADISON TAYLOR 1758 §103§112 Non-Final OA 34d Pending Oct 18, 2022

Managing Ortiv-Q3 Research Pvt Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month